Jade BiosciencesJBIO
13F holders, Q3 2025 (September 30)78holders +5
8new positions
3sold out
$8.63avg. 13F price*
At the end of Q3 2025, 78 institutions reported holding Jade Biosciences Inc. (JBIO) in their 13F filings, up 5 from Q2 2025. 8 opened new positions and 3 sold out. The largest holders were FMR LLC ($42.2M), Fairmount Funds Management LLC ($27.8M) and Venrock Adviser, LLC ($27.8M).
- Company
- Jade Biosciences Inc.
- CUSIP
- 008064206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $3.3M |
| Exits | 3 | $1.7M |
All 13F filers, Q2 2025 → Q3 2025: 1,249,524 shares bought and 1,163,651 shares sold, net +85,873 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 78 holders
| FMR LLC | 0.00% | Add +1.1% | 4,888,781 | $42.2M |
| Fairmount Funds Management LLC | 2.50% | No change | 3,220,368 | $27.8M |
| Venrock Adviser, LLC | 1.56% | No change | 3,220,364 | $27.8M |
| Deep Track Capital, LP | 0.55% | Reduce -9.1% | 2,279,892 | $19.7M |
| BlackRock, Inc. | 0.00% | Add +25.4% | 2,150,203 | $18.6M |
| Vanguard Group Inc. | 0.00% | Reduce -4.5% | 1,726,744 | $14.9M |
| Versant Venture Management, LLC | 6.20% | No change | 1,525,820 | $13.2M |
| RTW Investments, LP | 0.15% | No change | 1,449,273 | $12.5M |
| Frazier Life Sciences Management, L.P. | 0.37% | Reduce -20.3% | 1,413,280 | $12.2M |
| Driehaus Capital Management LLC | 0.08% | No change | 1,255,798 | $10.8M |
| Avidity Partners Management LP | 2.21% | No change | 1,127,186 | $9.7M |
| Ra Capital Management, L.P. | 0.11% | No change | 1,062,326 | $9.2M |
| Soleus Capital Management, L.P. | 0.37% | No change | 796,744 | $6.9M |
| Geode Capital Management, LLC | 0.00% | Reduce -1.6% | 665,915 | $5.7M |
| Great Point Partners LLC | 2.28% | Add +27.0% | 632,599 | $5.5M |
| Logos Global Management LP | 0.53% | No change | 625,000 | $5.4M |
| Samsara Biocapital, LLC | 0.60% | No change | 531,163 | $4.6M |
| Orbimed Advisors LLC | 0.11% | No change | 531,163 | $4.6M |
| Deerfield Management Company, L.P. | 0.08% | No change | 531,163 | $4.6M |
| State Street Corp. | 0.00% | Add +56.6% | 499,287 | $4.3M |
| Northern Trust Corp. | 0.00% | Add +0.7% | 229,581 | $2.0M |
| Goldman Sachs Group Inc. | 0.00% | New | 162,711 | $1.4M |
| Wellington Management Group LLP | 0.00% | New | 107,553 | $928K |
| Sofinnova Investments, Inc. | 0.06% | No change | 107,391 | $927K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -9.7% | 93,250 | $805K |
| Bank of New York Mellon Corp | 0.00% | Add +5.0% | 82,351 | $711K |
| Affinity Asset Advisors, LLC | 0.05% | No change | 65,317 | $564K |
| Morgan Stanley | 0.00% | Add +9.0% | 54,241 | $468K |
| Barclays PLC | 0.00% | Reduce -83.3% | 45,767 | $395K |
| Rhumbline Advisers | 0.00% | Reduce -4.0% | 42,784 | $369K |
| Nuveen, LLC | 0.00% | Reduce -28.9% | 42,748 | $369K |
| XTX Topco Ltd | 0.02% | Add +56.5% | 40,297 | $348K |
| Marshall Wace, LLP | 0.00% | New | 38,080 | $329K |
| Invesco Ltd. | 0.00% | New | 34,576 | $298K |
| Deutsche Bank AG | 0.00% | Add +15.6% | 29,596 | $255K |
| Quantinno Capital Management LP | 0.00% | Add +22.7% | 26,975 | $233K |
| Wells Fargo & Company | 0.00% | Add +19.4% | 24,870 | $215K |
| Two Sigma Investments, LP | 0.00% | New | 24,610 | $212K |
| UBS Group AG | 0.00% | Reduce -5.7% | 19,831 | $171K |
| Susquehanna International Group, LLP | 0.00% | Reduce -55.0% | 17,653 | $152K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 16,256 | $141K |
| Deltec Asset Management LLC | 0.02% | No change | 15,756 | $136K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -14.3% | 15,222 | $131K |
| BNP Paribas Financial Markets | 0.00% | Add +363.4% | 14,931 | $129K |
| Bank of America Corp. | 0.00% | Add +1.6% | 14,580 | $126K |
| Intech Investment Management LLC | 0.00% | Reduce -38.6% | 14,122 | $122K |
| MetLife Investment Management, LLC | 0.00% | New | 13,284 | $115K |
| JPMorgan Chase & Co. | 0.00% | Reduce -14.1% | 13,198 | $114K |
| Alliancebernstein L.P. | 0.00% | No change | 12,054 | $104K |
| Corient Private Wealth LP | 0.00% | Add +15.9% | 11,741 | $101K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -3.0% | 11,072 | $96K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | Add +46.0% | 10,388 | $90K |
| Group One Trading LLC | 0.00% | No change | 5,268 | $45K |
| New York State Common Retirement Fund | 0.00% | Add +4180.3% | 5,222 | $45K |
| Russell Investments Group, Ltd. | 0.00% | Add +40.7% | 4,422 | $38K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 3,312 | $29K |
| Legal & General Group Plc | 0.00% | No change | 2,954 | $25K |
| Sterling Capital Management LLC | 0.00% | Add +155.5% | 2,238 | $19K |
| California State Teachers Retirement System | 0.00% | New | 2,031 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -38.3% | 1,905 | $16K |
| Citigroup Inc. | 0.00% | Reduce -86.9% | 1,592 | $14K |
| Royal Bank of Canada | 0.00% | Reduce -72.4% | 1,020 | $9K |
| STRS Ohio | 0.00% | Reduce -81.6% | 900 | $8K |
| GAMMA Investing LLC | 0.00% | Add +43.3% | 182 | $2K |
| Arax Advisory Partners | 0.00% | Add +5066.7% | 155 | $1K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -75.5% | 83 | $716 |
| Farther Finance Advisors, LLC | 0.00% | Add +381.3% | 77 | $665 |
| Nisa Investment Advisors, LLC | 0.00% | New | 43 | $371 |
| SBI Securities Co., Ltd. | 0.00% | Add +575.0% | 27 | $233 |
| Principal Securities, Inc. | 0.00% | Reduce -61.5% | 5 | $43 |
| Rothschild Investment LLC | 0.00% | Reduce -83.3% | 5 | $43 |
| Jones Financial Companies LLLP | 0.00% | No change | 2 | $17 |
| Assetmark, Inc. | 0.00% | No change | 1 | $9 |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -85.7% | 1 | $9 |
| Amalgamated Bank | 0.00% | No change | 9 | $0 |
| Cwm, LLC | 0.00% | Reduce -52.5% | 57 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 6 | $0 |
| Avion Wealth | 0.00% | No change | 7 | $0 |
"% of holder's portfolio" is JBIO's weight in each manager's 13F, not the share of Jade Biosciences Inc. the manager owns.